ReviewNeurosurgical review2025
Non-invasive versus invasive techniques for predicting idiopathic normal-pressure hydrocephalus in shunt-responsive patients.
Review in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of normal-pressure hydrocephalus (NPH) can be challenging, particularly distinguishing between shunt-responsive and non-responsive patients. Overlapping clinical symptoms with aging and neurodegenerative diseases such as Alzheimer’s and Parkinson’s may hinder its diagnosis. Thus, more effective diagnostic tools are necessary To compare non-invasive techniques, such as electroencephalography (EEG), transcranial Doppler (TCD), intracranial compliance (ICC) measurement, and optical coherence tomography (OCT), with invasive procedures, such as lumbar puncture (LP) and infusion tests (IT), in the prediction of shunt responsiveness in patients with idiopathic normal pressure hydrocephalus (iNPH). A systematic search of PubMed, Embase, and the Cochrane Library from 2013 to March 2023 identified studies that evaluated both invasive procedures (e.g., LP, IT) and non-invasive methods (e.g., EEG, TCD, ICC, OCT). Ten studies including 401 elderly patients with iNPH were analyzed. EEG biomarkers consistently differentiated responders, with three reproducible patterns: decreased frontal theta/delta power, increased temporal gamma power (sensitivity 83%, specificity 88%), and alpha rhythm normalization. Non-responders showed persistent slow delta waves in the frontal region and beta asymmetry. TCD revealed a 20% increase in the middle cerebral artery flow velocity after cerebrospinal fluid withdrawal in responders, correlating with motor improvement. OCT showed thinner ganglion cell layers in responders, while ICC suggested changes in brain compliance. Combined, these biomarkers may contribute to a more comprehensive predictive framework. While promising, non-invasive iNPH biomarkers remain insufficiently validated. No non-invasive test currently matches the reliability of invasive methods, which continue to represent the gold standard. Long-term data are lacking, and these tools should be considered as complementary rather than replacements for standard diagnostics.
Indexed as
Identifiers
41145826What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.